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Abstract: The dissemination of multidrug-resistant Gram-negative bacteria (MDR-GNB) is associated
with increased morbidity and mortality in several countries. Machine learning (ML) is a branch of
artificial intelligence that consists of conferring on computers the ability to learn from data. In this
narrative review, we discuss three existing examples of the application of ML algorithms for assessing
three different types of risk: (i) the risk of developing a MDR-GNB infection, (ii) the risk of MDR-GNB
etiology in patients with an already clinically evident infection, and (iii) the risk of anticipating the
emergence of MDR in GNB through the misuse of antibiotics. In the next few years, we expect to
witness an increasingly large number of research studies perfecting the application of ML techniques
in the field of MDR-GNB infections. Very importantly, this cannot be separated from the availability
of a continuously refined and updated ethical framework allowing an appropriate use of the large
datasets of medical data needed to build efficient ML-based support systems that could be shared
through appropriate standard infrastructures.
Keywords: antimicrobial resistance; Gram-negative; MDR; machine learning
1. Introduction
Multidrug-resistant Gram-negative bacteria (MDR-GNB) have now become endemic in several
countries [1–4]. From a clinical perspective, the dissemination of MDR-GNB carries an increased risk
of inadequately treating patients with severe infections caused by these organisms, in part for the
following two reasons: (i) as per definition, MDR-GNB are concomitantly resistant to multiple classes
of antibiotics, thereby increasing the chance of selecting an inactive empirical treatment, and (ii) even
once susceptibility test results become available (usually 48–72 h after the onset of the disease and the
initiation of empirical treatment), their targeted treatment could remain suboptimal, since the MDR
phenotype may force clinicians to choose among very few remaining options, including nephrotoxic
agents or agents with impaired pharmacokinetics in some sites of infection [5]. Fortunately, some novel
antibiotics have recently become available, that have enriched our armamentarium and have improved
our ability to effectively counteract some of these deadly infections [6–9]. Nonetheless, this renewed
availability of effective agents raises another important need, that of preserving the activity of these
novel agents in the long term, by using them wisely according to antibiotic stewardship principles [10].
Overall, this complex scenario has inspired three important lines of clinical research to ultimately
help physicians dealing with MDR-GNB in clinical practice: (i) identification of patients at risk
of MDR-GNB infections (endpoint: development of MDR-GNB infection), (ii) identification of
the best interventions (treatments) to improve the prognosis of MDR-GNB infections (endpoints:
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clinical cure/mortality), and (iii) identification of interventions (infection-control and antimicrobials
stewardship measures) to counteract emergence and dissemination of resistance (endpoints: prevalence
of resistance/incidence rates of MDR-GNB infections).
To these aims, clinical research mostly relied (and relies) on classical predictive models, which
have been able to provide very useful risk scores to assist clinicians’ choices at the bedside of patients
at risk of (or with) MDR-GNB infections [11–13]. Nonetheless, in recent years there has also been an
increasing interest in exploiting the aid of machine learning (ML) techniques to better assist clinicians
in complex bedside tasks. Indeed, starting from patients’ data, ML clinical decision support systems
are able to learn the association between patients’ characteristics (input features of ML algorithms) and
the endpoints of interest (output labels of ML algorithms). Notably, this is not dissimilar from what
classical statistical models do (i.e., pointing out an association between patients’ characteristics and
a given outcome measure). Consequently, classical and ML-based risk prediction through ML may
be viewed as partly overlapping techniques, with the distinction between their aims and application
being not always so clear. Nonetheless, this overlapping is not necessarily a disadvantage, and in
our opinion, these two approaches should be ultimately viewed as complementary (to exploit their
respective advantages according to the characteristics of any given task and the magnitude of the
available data).
In this narrative review, we address the potential role of ML algorithms for assessing three different
types of risk: (i) the risk of developing a MDR-GNB infection, (ii) the risk of MDR-GNB etiology in
patients with an already clinically evident infection, and (iii) the risk of anticipating the emergence
of MDR in GNB through the misuse of antibiotics. We will employ a case study approach, i.e., by
selecting and discussing one existing example of the implementation of ML algorithms for each type of
the three risks mentioned above.
2. Methods
In October 2019 we performed a PubMed search, employing the following search strings:
(i) machine learning AND Gram-negative, and (ii) machine learning AND (antimicrobial resistance OR
antimicrobial stewardship). By means of title and abstract screening, from an initial total of 247 papers
we first selected only those studies pertaining to the use of ML algorithms for possibly guiding clinical
decisions. Then, following evaluation of full texts and references of selected papers, we ultimately
retained only those studies investigating the use of machine learning for measuring/classifying the
risk of either developing or having an infection due to MDR-GNB, or of prompting the emergence of
resistance. Eventually, we collectively selected a single pertinent example for narratively discussing
each of the three topics introduced above.
The present review is structured in the following sections: (i) ML in brief, (ii) ML algorithms for
predicting the risk of developing MDR-GNB infections, (iii) ML algorithms for predicting the risk of
MDR-GNB etiology in patients with sign and symptoms of infection, and (iv) ML algorithms to guide
antibiotic stewardship and preventing further emergence of MDR-GNB.
3. ML in Brief
ML is a branch of artificial intelligence that consists of conferring on computers the ability to learn
from data [14,15]. Differently from classical computer expert systems, which are explicitly programmed
to do specific task/s (e.g., recognizing a patient to be at risk of MDR-GNB infection), ML algorithms
have a notable advantage in term of flexibility, since they may be able to point out the association
between patients’ characteristics (the input) and the risk of MDR-GNB infection (the output) without
being explicitly programmed to do so [16].
As anticipated in the introduction, this overlaps with what classical statistical risk prediction
models do, since they also are able to predict associations between specific data and specific outcomes
by employing/adapting different models (e.g., linear regression, logistic regression, Cox regression,
or other models, dependent of the type of data and the nature of the assessed endpoint/s). It is
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thus not surprising that most introductory courses on ML start with lessons on linear regression and
logistic regression.
Consequently, classical statistical models and ML algorithms should be considered as a continuum
in which, generally, the fewer the assumptions imposed by humans (e.g., human-made strict selection
of variables to be included in the model) the more likely it is for ML algorithms to capture complex and
composite characteristics (features) not easily recognized by humans, and to evaluate their association
with the output label/s with high accuracy [17]. In this regard, two important concepts should
necessarily be taken into account. First, capturing/designing complex features usually requires a far
larger amount of data than usually needed for classical risk prediction (the fields of ML and “big
data” are indeed deeply intertwined) [18]. Second, the general assumption made just above (i.e.,
less human guidance coupled with increased use of ML algorithms) should be viewed more as a
background trend (over the continuum of classical statistical models and ML algorithms) rather than
an absolute rule. Indeed, human involvement also remain crucial in some complex tasks performed by
ML algorithms (as an important guidance for pre-processing data, defining the algorithm architecture,
appropriately tuning the algorithm hyperparameters, reducing/eliminating biases, and preserving
model interpretability). In addition, less complex ML algorithms and/or ML algorithms with more
human guidance may be used in addition to classical statistical approaches for the analysis of more
restricted databases, still possibly providing useful, complementary information.
In the following sections, we will further explore these concepts by reviewing some examples of
existing studies that implemented ML algorithms in the field of MDR-GNB infections. In addition,
different ML algorithms are schematically summarized in Table 1.
Table 1. Simplified presentation of the possible use of different machine learning algorithms (also
based on already existing and well-established statistical models) *.
UNSUPERVISED SUPERVISED
Clustering and dimensionality reduction Regression tasks
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In the following sections, we will furth r explore these concepts by reviewing some examples of 
existing studies that implemented ML algorithms in the field of MDR-GNB infections. In addition, 
different ML algorithms are schematically summarized in Table 1. 
Table 1. Simplified presentation of the possible use of different machine learning algorithms (also 
based on already existing and well-established statistical models)*. 
UNSUPERVISED SUPERVISED 
Clustering and dimensionality reduction Regression tasks 
 SVD (singular value decomposition)  Linear 
 PCA (principal component analysis)  Polynomial 
 K-means  Decision trees 
 Fuzzy k-means  Random forest 
 Hierarchical clustering  
 Mixture of Gaussians  
 SOM (self-organizing maps)  
Association analysis Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent pattern)-growth  K-nearest neighbor 
Hidden Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear discriminant analysis) 
* This is only a fraction of available machine learning algorithms and distinctions in categories are not 
absolute. For example, some techniques presented for classification problems in the table may also be 
used for regression problems, and some algorithms/techniques may be used for both supervised and 
unsupervised objectives. 
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
In this section, we describe a case example of a recent study exploiting he use of ML algorithms 
for depicting the risk of colonization [19] by extended-spectrum β-lactamases (ESBL)-producing 
Enterobacterales (ESBL-PE), a type of MDR-GNB. Indeed, although colonization by MDR-GNB is not 
always followed by MDR-GNB infection (i.e., colonized patients may not develop infection), the latter 
usually follows the former. Consequently, identifying modifiable risk factors on which to intervene 
for reducing the risk of colonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
SVD (singular value decomposition)
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Consequently, classical statistical models and ML algorithms should be considered as a 
continuum in which, generally, the fewer the ssumptions imposed by humans (e.g., human-made 
strict selection of variables to be included in the model) the more likely it is for ML algorithms to 
capture c mplex and composite characteristics (features) not easily recognized by humans, and to 
evaluate their association with the output label/s with high accuracy [17]. In this regard, two 
important concepts sho ld nec sar ly be taken into account. First, capturing/designing complex 
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(th  fields of ML and “big data” are indeed deeply intertwined) [18]. Second, the general as um tion 
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viewed ore as a background tren  (over the continuum of classical statistical models and ML 
algorithms) rather th n an absolute rule. Indeed, human involvement also remain crucial in some 
complex tasks performed by ML algorithms ( s an important guidance for pre-processing data, 
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statistical approaches for the analysis of more restricted databases, still possibly providing useful, 
complementary information. 
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existing studies that implemented ML algor hms in the field of MDR-GNB infections. In addition, 
different ML algorithms are schematically summarized in Table 1. 
Table 1. Simplifi d p esentation of the possible use of different machine learning algorithms (also 
base  on already existing and well-established statistical models)*. 
UN UPERVISED SUPERVISED 
Clustering and dimensionality reduction Regression tasks 
 SVD (singul r value decompos n)  Linear 
 PCA (principal component analysis)  Polynomial 
 K-m ans  Decision trees 
 Fuzzy k-means  Random forest 
 Hierarchical clustering  
 Mixture of Gaussians  
 SOM (self-organizing maps)  
Association analysis Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent pattern)-growth  K-nearest neighbor 
Hidde  Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear discriminant analysis) 
* This i o ly a fraction of av ilable machi e learning algorithms and distinctions in categories are not 
bsolute. For example, some techniques presented for classification problems in the table may also be 
used for regression problems, and some lgorithms/techniques may be used for both supervised and 
unsupervised objectives. 
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
I  this section, we describ a case example of a recent study exploiting he use of ML algorithms 
for depicting the risk of colonization [19] by extended-spectrum β-lactamases (ESBL)-producing 
Enterobacterales (ESBL-PE), a t pe of MDR-GNB. Indeed, although colonization by MDR-GNB is not 
always followed by MDR-GNB infection (i.e., colonized patients may not develop infection), the latter 
usually follows the former. Consequently, identifying modifiable risk factors on which to intervene 
for reducing the risk of c lonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
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Consequently, classical statistical models and ML algorithms s ould be considered as a
continuum in which, generally, the few r the assump i ns imp s d by hum ns ( .g., h man- ade
strict s lection of variables to be included in the model) the more lik ly it is for ML algorithms
capt re complex and composite c aracteristics (features) not easily e ognized by umans, and t
evaluate their association with the outpu  label/s with high accuracy [17]. In this regard, two
impo tant concepts should necessarily be aken into acco nt. First, capturing/designing complex
featur s usually requires a f r larg r mount of data han usually needed for classical r sk predic
(the fields of ML and “big data” are indeed dee ly intertwined) [18]. S c nd, the general s umption
made just above (i.e., less h man gui ance coupled with increased use of ML algorithms) should be
viewed ore as a background trend (over the continuu  of classical st tistic l models a  ML
algorithms) rather than an absolute rule. Indeed, human involvement also remain crucial in some
complex tasks performed by ML algorithms (as an impor nt guidance for pre-proc ssing data
defining the algorithm architecture, appropriately tuning the algorithm hyperparameters,
reducing/eliminating biases, and preserving mode  interpret bilit ). In ad ition, less comp ex ML
algorithms and/or ML algorithms w th more human gu dance may b  used in ddition to cla sical
statistical approaches for the analysis of more restricted databases, still possibly providing useful, 
complem ntary informa . 
I  the following sections, w  will further explore se conc pts by reviewing s me examples of
existing studies that i plement d ML algorith s n th  field of MDR-GNB infections. In addition, 
different ML algorithms are schematically summarized in Table 1. 
T ble 1. Simplified presentation of the possible use of differ nt machin  lear ing algorithms (also 
based on already existing and well-established statistical models)*. 
UNSUPERVISED SUPERVISED 
Clustering and dimensionality reduction Regression tasks 
 SVD (singular value decomposition)  Linear 
 PCA (principal component analysis)  Polynomial 
 K-means  Decision trees 
 Fuzzy k-means  Random forest 
 Hierarchical clustering  
 Mixture of Gaussians  
 SOM (self-organizing maps)  
Association analysis Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent pattern)-growth  K-nearest neighbor 
Hidden Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear dis r minant nalysis)
* This is only a fraction of available machin  l arning algorithms a d distinctio  in c tegories re not 
absolute. Fo  example, some techniques presented for lassification problems in the table may also be 
sed fo  regression problems, and some algorithms/techniq es may be us d for both supervised and 
unsupervised objectives. 
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
In this section, we describe a case example of a recent s udy exploiting he u e of ML alg rithms
for depicting the risk of colonization [19] by exte d -spectrum β-lactamases (ESBL)-producing
Enterobacterales (ESBL-PE), a type of MDR-GNB. Indeed, although col nization by MDR-GNB is n t
alw ys fol o ed by MDR-GNB infection (i.e., colonized patients may not devel p i f ctio ), th  latter
usually follows the former. Consequently, identifying modifiable risk factors n which to intervene
for reducing the risk of colonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
PCA (pr ncipal component anal is)
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Consequently, classic l statistical models and ML algorithms s ould be considered as a
co inuum in w ich, generall , the few r the ssumptions imp s d by humans (e.g., human- ade
strict lec ion of variables to e included i  the model) the more lik ly it is for ML algorithms
capt re c mplex and composite c aracteristics (features) not easily e ognized by umans, and t
evaluate their a so iation with the outpu  label/s with high accuracy [17]. In this regard, two
impo tant concepts sho ld nec sar ly b  aken into acco nt. First, capturing/designing complex
featur s usually r quires a f r larg  amo nt of data ha  us ally needed for lassical risk predic
(th  fields of ML and “big d ta” are indeed dee ly intertwined) [18]. S c nd, the general as umption
made j st above (i.e., less h m n guidance coupl d with increased use of ML algorithms) should be
viewed ore as a background tren  (over the continuum of classical statistic l models a d ML
algorithms) rather th n an absolute rule. Indeed human involvement also remain crucial in some
compl x tasks performed by ML algorith s ( s n important guidance for pre-processing data
defining he algorithm archit ctu e, ppropriately tuning the algorithm hyperparameters,
reducing/ liminating biases, n  preserving model interpretabilit ). In ad ition, less comp ex ML
lgorithms and/or ML algorithms w th more h man guidance may be used in addition to cla sical
statistical approaches for the analysis of more restricted databases, still possibly providing useful, 
complem ntary informa . 
I  the following s ctions, w  will further explore se concepts by reviewing s me examples of
existing studies that i plement d ML algor h s n the field of MDR-GNB infections. In addition, 
different ML algorithms are schematically summarized in Table 1. 
T ble 1. Simplified p esentation of the possible use of differ nt machine learning algorithms (also 
base  on already existing and well-established statistical models)*. 
UN UPERVISED SUPERVISED 
Clustering and dimensionality reduction Regression tasks 
 SVD (singular value decomposition)  Linear 
 PCA (principal component analysis)  Polynomial 
 K-m ans  Decision trees 
 Fuzzy k-means  Random forest 
 Hierarchical clustering  
 Mixture of Gaussians  
 SOM (self-organizing maps)  
Association analysis Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent pattern)-growth  K-nearest neighbor 
Hidde  Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear dis r minant nalysis)
* This i ly a fraction of av ilable machi  l arning algorithms a d distinctio s in c tegories re not 
bsolute. Fo  xample, some techniqu s presented for lassification problems in the table may also be 
sed fo  regression problems, and some lgorithms/techniques may be used for both supervised and 
unsupervised objectives. 
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
I  this section, we describ a case example of a recent study exploiting he u e of ML alg rithms
for depic ing t e risk of colonization [19] by extend -spectrum β-lactamases (ESBL)-producing
Enterobacterales (ESBL-PE), a t p  of MDR-GNB. Indeed, although col nization by MDR-GNB is not
alw ys fol o d by MDR-GNB infection (i.e., colonized patients may not devel p infection), th  latter
usu lly follows the former. Consequently, identifying modifiable risk factors n which to intervene
for reducing the risk of c lonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
Poly ial
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Consequently, cl ssical statistic l models and ML alg rithms s o ld be conside ed as a 
on inuum in which, generally, the few r the assum tions i s d by hu an  ( .g., h man- ade 
strict s lection of variables to be included in the model) t e more lik l  it is for ML algorithms  
capt re complex and c mposite c aracteristics (fea ures) ot easily e ognized by umans, and t  
eval ate their association with the outpu  label/s with high accuracy [17]. In this regar , wo 
impo tant concepts shoul  necessarily be aken into acco nt. First, capturing/designing complex 
fe tur s usually requir  a f r l rg r amount of data han usually needed for cl ssical r sk pr dic  
(the fields f ML and “bi  data” a  indeed dee ly i tertwined) [18]. S c nd, the general s umption 
made just above (i.e., less h man gui ance coupled with increased use of ML lg rithms) should b  
viewed ore as a background trend (over the continuu  of classical st tistic l m d l  a  ML 
algorithms) rather than an absolute ule. Indeed, huma  i volvement also re ain cruci l in some 
complex tasks performed by ML algo ithms (as an important guida ce for pre-pro ssing data  
defining the algorithm arc itecture, appropri tely tuning the algorithm hyperparam ters, 
reducing/elimin ting biases, and pre erving mode  interpret bilit ). In ad ition, les  comp ex ML 
algorith s and/or ML lgorithms w th more human gu dance may b  used in ddition to cla sical
statistical approaches for the analysis of mor  rest ic ed da abases, still possibly providing us ful, 
complem ntary infor a . 
I  the following section , we will further explore se conc pts by reviewing s me examples of
existing studies that i plement d ML algorith s n th  field of MDR-GNB infections. In addition, 
different ML algorithms are schematically summarized in Table 1. 
T ble 1. Simplified presentation of the possible use of differ nt machin  lear ing algorithms (also 
based on already existing and well-established statistical models)*. 
UNSUPERVISED SUPERVISED 
Clustering and dimensionality reduction Regression tasks 
 SVD (singular value decomposition)  Linear 
 PCA (principal component analysis)  Polynomial 
 K-means  Decision trees 
 Fuzzy k-means  Random forest 
 Hierarchical clustering  
 Mixture of Gaussians  
 SOM (self-organizing maps)  
Association analysis Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent pattern)-growth  K-nearest neighbor 
Hidden Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear dis r minant nalysis)
* This is only a fraction of available machin  l arning algorithms a d distinctio  in c tegories re not 
absolute. Fo  example, some techniques presented for lassification problems in the table may also be 
sed fo  regression problems, and some algorithms/techniq es may be us d for both supervised and 
unsupervised objectives. 
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
In this section, we describe a case example of a r cent s udy xploiting he u e of ML alg rithms 
for depicting the risk of colonization [19] by exte -spectrum β-lactamases (ESBL)-producing 
Enterobacterales (ESBL-PE), a type of MDR-GNB. Indeed, alth ugh col nization by MDR-GNB is t 
alw ys fol o ed by MDR-GNB infection (i.e., colonized patie ts may not devel p i f ctio ), th  lat er 
usually follows the former. Consequently, identifying m difiable risk factors n which to intervene
for reducing the risk of colonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
K-means
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Consequently, cl ssic  statistical models nd ML algorithms s uld be conside ed as a 
on inuum in which, ge erally, the few r the ssumptions imp s d by humans (e.g., human- ade 
strict lec ion of v riables to e included i  he model) t e more lik l  it is for ML algorithms  
capt re c mplex and c mposite c aracteristics (fea ures) not easily e ognized by umans, and t  
eval ate their a so iati n with the outpu  label/s with high accuracy [17]. In this regar , wo 
impo tant concepts sho l  nec sar ly b  aken into account. First, capturing/designing complex 
fe tur s usu lly r quir  a f r l g  amo nt of data han usually needed for cl ssical risk predic  
(th  fields f ML and “bi  d ta” a  indeed dee ly i tertwined) [18]. S c nd, the general as umption 
made j st above (i.e., le s h  guidance coupled with increased use of ML algorithms) should b  
viewed ore as a ba kground tren  (over the continuum of classical statistic l m d l  a d ML 
lgorith s) rath r th n a  absolu e ule. Indeed, human volvement also re ain cruci l i some 
complex tasks performe  by ML alg ith s ( s an important guida ce for pre-pro essing data  
defining he lgorithm arc it ctu e, ppropri tely tuning the algorithm hyperparameters, 
reducing/ limin ting biases, an  pre erving model interpretabilit ). In ad ition, less comp ex ML 
lgorith s and/or ML lgorithms w th more h man guidance may be used in addition to cla sical
statistical approach s for the analysis of or  rest ic ed databases, still possibly providing us ful, 
complem ntary infor a . 
I  the following s ction , we will further explore se concepts by reviewing s me examples of
existing studies that i plement d ML algor h s n the field of MDR-GNB infections. In addition, 
different ML algorithms are schematically summarized in Table 1. 
T ble 1. Simplified p esentation of the possible use of differ nt machine learning algorithms (also 
base  o  alrea y existi g and well-established statistical models)*. 
UN UPERVISED SUPERVISED 
Clustering and dimensionality reduction Regression tasks 
 SVD (singular value decomposition)  Linear 
 PCA (principal component analysis)  Polynomial 
 K-m ans  Decision trees 
 Fuzzy k-means  Random forest 
 Hierarchical clustering  
 Mixture of Gaussians  
 SOM (self-organizing maps)  
Association analysis Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent pattern)-growth  K-nearest neighbor 
Hidde  Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear dis r minant nalysis)
* This i ly a fraction of av ilable machi  l arning algorithms a d distinctio s in c tegories re not 
bsolute. Fo  xample, some techniqu s presented for lassification problems in the table may also be 
sed fo  regression problems, and some lgorithms/techniques may be used for both supervised and 
unsupervised objectives. 
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
I  this section, we descri a case example f a r cent s udy exploiting he u e of ML alg rithms 
for depic ing t e risk of c lonization [19] by xten -spectrum β-lactamases (ESBL)-producing 
E terobacterales (ESBL-PE), a t pe of MDR-GNB. Indeed, although col nization by MDR-GNB is not 
alw ys f l o d by MDR-GNB inf ction (i.e., colonized patients may not devel p infection), th  latter 
usu lly follows the former. Consequently, identifying modifiable risk factors n which to intervene
for reducing the risk of c lonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
Decisi n trees
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Consequently, cl ssical statistic l models and ML alg rithms s uld be conside ed as a
on inuum in which, generally, the few r the ssum tions i s d by hu an  ( .g., h m n- d
strict s lecti  of variables to b  included in the model) t e mor  lik l  it is for ML algorith s
capture complex and c mposite c aracteristics (fe ures) ot easily e ognized by umans, and t
eval ate their association with the outpu  label/s with high accuracy [17]. In this r gar , two
i po tant conc pts shoul  necessarily b  aken into acco nt. First, capturing/designing c mplex
fe tur s usually requir  a f r l rg r am unt of data han usually needed for cl ssical r sk pr dic
(the fields f ML and “bi  d ta” a  indeed de ly i tertwined) [18]. S c d, the ge eral s umption
made just bove (i.e., less h man gui ance coupled with increased use of ML lg rithms) should b
viewed or  as a background trend (over the conti uu  of cl ssic l st tistic l m d l   ML
algorithms) rather than an absolute ule. Indeed, huma  i volveme t also re ain cruci l i some
complex tasks performed by ML algo ithms (as  important guida ce f r pre-pr ssing dat
defining the algorithm arc itecture, appropri tely tuning the alg rit m hyperparam ters,
reducing/ limin ting biases, and pre erving mode  interpr t bilit ). In ad ition, les  comp ex ML 
algorith s and/or ML lgorithms w th more human gu dance may  used in ddition to cla sical
statistical approaches for the analysis of mor  rest icted databases, still possibly providin  us ful, 
complem ntary infor a . 
I  the following section , we will further explore se conc pts by reviewing s me examples of
existing studies that i plement d ML algorith s n th  field of MDR-GNB infections. In addition, 
different ML algorithms are schematically summarized in Table 1. 
T ble 1. Simplified presentation of the possible use of diff r t machin  lear ing algorithms (also 
based on already existing and well-established statistical models)*. 
UNSUPERVISED SUPERVISED 
Clustering and dimensionality reduction Regression tasks 
 SVD (singular value decomposition)  Linear 
 PCA (principal component analysis)  Polynomial 
 K-means  Decision trees 
 Fuzzy k-means  Random forest 
 Hierarchical clustering  
 Mixture of Gaussians  
 SOM (self-organizing maps)  
Association analysis Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent pattern)-growth  K-nearest neighbor 
Hidden Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear dis r minant nalysis)
* This is only a fraction of available machin  l arning algorithms a d distinctio  in c tegories re not 
absolute. Fo  example, some techniques presented for lassification problems in the table may also be 
sed fo  regression problems, and some algorithms/techniq es may be us d for both supervised and 
unsupervised objectives. 
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
In this section, we describe a case example f  r cent s udy xploiting he u e of ML alg rithms
for depicting the risk of colonization [19] by exte -spectrum β-lactamases (ESBL)-produci g
Enterobacterales (ESBL-PE), a type of MDR-GNB. Indeed, alth ug col nization by MDR-GNB is t
alw ys fol o ed by MDR-GNB infection (i.e., colonized patie ts may not devel p i f ctio ), th  lat er 
usually follows the former. Consequently, identifying m difiable risk factors n which to intervene
for reducing the risk of colonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
Fuzzy k- eans
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Consequently, cl ssic l statistic l models and ML algorithms s ould be conside ed as a
on inuum in which, ge erally, t e few r the ssumptions imp s d by humans (e.g., hum n- ade
strict lec i  of v riables to included i  he model) t e more lik l  it is for ML algorith s
capture c mplex and c mposite c aracteristics (fe ures) not easily e ognized by umans, and t
eval ate th ir a so iati n with the outpu  label/s w th high accuracy [17]. In this regar , two
i po ta t conc pts sho l  nec sar ly b  aken into acco nt. First, capturing/designing c plex
fe tur s usu lly r quir  a f r la g  am t of data han usually needed for cl ssical risk predic
(th  fields f ML and “bi  d ta” a  indeed de ly i tertwined) [18]. S c nd, the ge eral as umption
made j st bove (i.e., le s h  guidance coupled with increased use of ML algorithms) should b
vi wed or  as a ba kgroun  tren  (over the continuum of c assic l statistic l m d l  nd ML
lgorithms) rather th n an absolute ule. Indeed, hu an i volvement also re ain cruci l in some
complex tasks perform  by ML alg ith s ( s  important guida ce for pre-pr essing dat
defining he lgorithm arc it ctu e, ppropri tely tuning the algorithm hyperparameters,
reducing/ limin ting biases, an  pre erving model interpretabilit ). In ad ition, less comp ex ML 
lgorith s and/or ML lgorithms w th more h man guidance may e used in addition to cla sical
statistical approaches for the analysis of or  rest icted databases, still possibly providing us ful, 
complem ntary infor a . 
I  the following s ction , we will further explore se concepts by reviewing s me examples of
existing studies that i plement d ML algor h s n the field of MDR-GNB infections. In addition, 
different ML algorithms are schematically summarized in Table 1. 
T ble 1. Simplified p esentation of the possible use of differ nt machine learning algorithms (also 
base  on already existing an  well-established statistical models)*. 
UN UPERVISED SUPERVISED 
Clustering and dimensionality reduction Regression tasks 
 SVD (si gular value decomposition)  Linear 
 PCA (principal component analysis)  Polynomial 
 K-m ans  Decision trees 
 Fuzzy k-means  Random forest 
 Hierarchical clustering  
 Mixture of Gaussians  
 SOM (self-organizing maps)  
Association analysis Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent pattern)-growth  K-nearest neighbor 
Hidde  Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear dis r minant nalysis)
* This i ly a fraction of av ilable machi  l arning algorithms a d distinctio s in c tegories re not 
bsolute. Fo  xample, some techniqu s presented for lassification problems in the table may also be 
sed fo  regression problems, and some lgorithms/techniques may be used for both supervised and 
unsupervised objectives. 
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
I  this section, we descri a case example f a r cent s udy exploiting he u e of ML alg rithms
for depic ing t e risk of colonization [19] by xte -spectrum β-lactamases (ESBL)-produci g
E terobacterales (ESBL-PE), a t pe of MDR-GNB. Indeed, although col nization by MDR-GNB is not
alw ys f l o d by MDR-GNB inf ction (i.e., colonized patients may not devel p infection), th  latter 
usu lly follows the former. Consequently, identifying modifiable risk factors n which to intervene
for reducing the risk of c lonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
Ra do forest
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Consequently, cl ssical statistic l models and ML alg rithms s uld be conside e  as a 
on inuum in which, generally, the few r the ssu tions i sed by hu an  ( .g., h m n-m d  
strict s lecti  of variables to b  included in the model) t e mor  lik l  it is for ML algorith s  
capture complex and c mposite c aracteri tics (f r s) ot asily e ognized by u a s, nd t  
eval ate their association with the outpu  label/s with high accuracy [17]. In this regar , two 
i po tant conc pts shoul  necessarily b  aken into acco nt. First, capturing/ esigning c mplex 
fe tur s usually requir  a far l rg r am unt of data han usually needed for classical r sk pr dic  
(the fields f ML and “bi  d ta” a  indeed de ly i tertwined) [18]. S c d, the ge eral s u ption 
made just bove (i.e., less h man gui ance cou led with increased use of ML lg rithms) should b  
viewed or  as a background trend (over the conti uu  of cl ssic l st tistic l m d l   L 
algorith s) rather than an absolute ule. Indeed, huma  i volveme t also re ain cruci l i some 
complex tasks performed by ML algo ithms (as  important guida ce f r pre-pr ssing dat  
defining the algorithm arc itecture, appropri tely tuning the alg rit m hyperparam ters,
reducing/elimin ting biases, and pre erving mode  interpret bilit ). In ad ition, les  comp ex ML 
algorith s and/or ML lgorithms w th more human gu dance may  used in ddition to cla sical
statistical approaches for the analysis of mor  rest icted databases, still possibly providin  us ful, 
complem ntary infor a . 
I  the following section , we will further explore se conc pts by reviewing s me examples of
existing studies that i plement d ML algorith s n th  field of MDR-GNB infections. In addition, 
different ML algorithms are schematically summarized in Table 1. 
T ble 1. implified presentation of the possible use of differ nt machin  lear ing algorith s (also 
based on already existing and well-established statistical models)*. 
UNSUPERVISED SUPERVISED 
Clustering and dimensionality reduction Regression tasks 
 SVD (singular value decomposition)  Linear 
 PCA (principal component analysis)  Polynomial 
 K-means  Decision trees 
 Fuzzy k-means  Random forest 
 Hierarchical clustering  
 Mixture of Gaussians  
 SOM (self-organizing maps)  
Association analysis Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent pattern)-growth  K-nearest neighbor 
Hidden Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear dis r minant nalysis)
* This is only a fraction of available machin  l arning algorithms a d distinctio  in c tegories re not 
absolute. Fo  example, some techniques presented for lassification problems in the table may also be 
sed fo  regression problems, and some algorithms/techniq es may be us d for both supervised and 
unsupervised objectives. 
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
In this section, we describe a case example f  r cent s udy xploiting he u e of ML alg rithms 
for depicting the risk of colonization [19] by exte -spectrum β-lactamases (ESBL)-produci g 
Enterobacterales (ESBL-PE), a type of MDR-GNB. Indeed, alth ug col nization by MDR-GNB is t
alw ys fol o ed by MDR-GNB infection (i.e., colonized patie ts may not devel p i f ctio ), th  lat er 
usually follows the former. Consequently, identifying m difiable risk factors n which to intervene
for reducing the risk of colonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
Hier chical clustering
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Consequently, cl ssical statistic l models and ML algorithms s ould be conside e  as a
on inuum in which, generally, the few r the ssu tions i sed by hu an  ( .g., hum n-m d
strict s lecti  of variables to b  included in the model) t e mor  lik l  it is for ML algorith s
capture complex and c mposite c aracteristics (fe ures) not easily e ognized by umans, and t
eval ate their association with the outpu  label/s ith high accuracy [17]. In this regar , two
i po tant conc pts shoul  necessarily b  aken into acco nt. First, capturing/ esigning c mplex
fe tur s usually requir  a far l rg r am unt of data han usually needed for classical risk pr dic
(the fields f ML and “bi  d ta” a  indeed de ply i tertwined) [18]. S c d, the ge eral as u ption
made just bove (i.e., less h man gui ance cou le  with increased use of ML lg rithms) should b
viewed or  as a background trend (over the conti uu  of classic l statistic l mod l  nd L
algorith s) rather than an absolute ule. Indeed, huma  i volveme t also re ain cruci l i some
co plex tasks perfor ed by ML algo ithms (as  important guida ce f r pre-pr essing dat  
defining the algorithm arc itecture, appropri tely tuning the alg rit m hyperpara ters,
reducing/elimin ting biases, and pre erving model interpretabilit ). In ad ition, les  comp ex ML 
algorith s and/or ML lgorithms w th more human guidance may e used in addition to cla sical
statistical approaches for the analysis of mor  rest icted databases, still possibly providin  us ful, 
complem ntary infor a . 
I  the following section , we will further explore se concepts by reviewing s me examples of
existing studies that i plement d ML algorith s n the field of MDR-G B infections. In addition, 
different ML algorithms are chematically summarized in Table 1. 
T ble 1. implified presentation of he po sible use of differ t achine learning alg rith s (als  
based on already existing and well-established statistical models)*. 
UNSUPERVISED SUPERVISED 
Clustering and dimensionality reduction Regression tasks 
 SVD (singular value decomposition)  Linear 
 PCA (principal component analysis)  Polynomial 
 K-means  Decision trees 
 Fuzzy k-means  Random forest 
 Hierarchical clustering  
 Mixture of Gaussians  
 SOM (self-organizing maps)  
Association analysis Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent pattern)-growth  K-nearest neighbor 
Hidden Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear dis r minant nalysis)
* This is only a fraction of available machin  l arning algorithms a d distinctio s in c tegories re not 
absolute. Fo  example, some techniqu s presented fo  lassification problems in the table may lso be 
sed fo  regr ssion problems, and some algorithms/techniques may be u ed for both supervised and 
unsupervised objectives. 
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
In this section, we describe a case example f  r cent s udy xploiting he u e of ML alg rithms
for depicting the risk of colonization [19] by exte -spectrum β-lactamases (ESBL)-produci g 
Enterobacterales (ESBL-PE), a type of MDR-GNB. Indeed, alth ug  col nization by MDR-GNB is ot
alw ys fol o ed by MDR-GNB infection (i.e., colonized patie ts may not devel p infection), th  lat er 
usually follows the former. Consequently, identifying m difiable risk factors n which to intervene
for reducing the risk of colonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
M xture of Gaussians
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Consequently, cl ssical statistic l models and ML algorithms s ould be conside ed as a 
on inuum in which, generally, the few r the ssu tions imp sed by humans (e.g., hum n-m d  
strict s lecti  of variables to b  included in the model) t e more lik l  it is for ML alg rith s  
capture complex and c mposite c aracteristics (fe ures) not easily e ognized by umans, and t  
eval ate their association with the outpu  label/s ith high accuracy [17]. In this regar , two 
i po tant conc pts shoul  necessarily b  aken into acco nt. First, capturing/ esigning c mplex 
fe tur s usually requir  a far l rg r am unt of data han usually needed for classical risk predic  
(the fields f ML and “bi  d ta” a  indeed de ply i tertwined) [18]. S c d, the ge eral as u ption 
made just bove (i.e., less h man gui ance cou le  with increased use of ML algorithms) should b  
viewed or  as a background trend (over the conti uu  of classic l statistic l mod l  nd L 
algorithms) rather than an absolute ule. Indeed, huma  i volveme t also re ain cruci l i some
co plex tasks perfor ed by ML algo ithms (as  important guida ce f r pre-pr essing dat  
defining the algorithm arc itecture, appropri tely tuning the alg rit m hyperparameters,
reducing/elimin ting biases, and pre erving model interpretabilit ). In ad ition, less comp ex ML 
algorith s and/or ML lgorithms w th more human guidance may e used in addition to cla sical
statistical approaches for the analysis of mor  rest icted databases, still possibly providin  us ful, 
complem ntary infor a . 
I  the following section , we will further explore se concepts by reviewing s me examples of
existing st di s th t i plement d ML algorith s n the field of MDR-G B infections. In addition, 
different ML algorithms re chematically summarized in Table 1. 
T ble 1. implified presentation of he po sible use of differ t achine learning alg rith s (als  
based on already existing and well-established statistical models)*. 
UNSUPERVISED SUPERVISED 
Clustering and dimensio ality reduction Regression tasks 
 SVD (si gular value decomposition)  Linear 
 PCA (principal component analysis)  Polyn mial 
 K-means  Decision trees 
 Fuzzy -means  Ran om forest 
 Hierarchical clustering  
 Mixture of Gaussians  
 SOM (self-organizing maps)  
Association analysis Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent pattern)-growth  K-nearest neighbor 
Hidden Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear dis r minant nalysis)
* This is only a fraction of avail ble machin  l arning algori ms a d distinctio  in c tegories re not 
absolute. Fo  example, some techniqu s present d  lassification problems in the table may ls  be 
sed fo  regr ssion problems, and some algorithms/techniques may be u ed for both supervised and 
unsupervised objectives. 
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
In this section, we describe a case example f  r cent s udy exploiting he u e of ML alg rithms
for depicting the risk of colonization [19] by exte -spectrum β-lactamases (ESBL)-produci g 
Enterobacterales (ESBL-PE), a type of MDR-GNB. Indeed, althoug  col nization by MDR-GNB is not
alw ys fol o ed by MDR-GNB infection (i.e., colonized patients may not devel p infection), th  latter 
usually follows the former. Consequently, identifying modifiable risk factors n which to intervene
for reducing the risk of colonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
SOM (self-organizing maps)
Associat alysis lassification tasks
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Consequently, cl ssical statistic l models and ML algorithms should be conside ed as a 
on inuum in which, generally, the fewer the ssumptions imposed by humans (e.g., hum n-made 
strict selecti  of variables to b  included in the model) t e more likel  it is for ML algorith s t  
capture complex and c mposite characteristics (fe ures) not easily recognized by humans, and to 
eval ate their association with the outpu  label/s ith high accuracy [17]. In this regar , two 
i portant conc pts shoul  necessarily b  taken in o account. First, capturing/design g c mplex 
fe tures usually requir  a far l rg r am unt of data than usually needed for cl ssical risk prediction 
(the fields f ML and “bi  d ta” a  indeed de ply i tertwined) [18]. Second, the ge eral assu ption 
made just bove (i.e., less human guidance cou led with increased use of ML algorithms) should b  
viewed mor  as a background trend (over the continuum of classic l statistical mod l  nd L 
algorithms) rather than an absolute ule. Indeed, human i volvement also re ain cruci l in some 
co plex tasks performed by ML algo ithms (as  portant guida ce for pre-pr essing dat , 
defining the algorithm arc itecture, appropri tely tuning the algorithm hyperparameters, 
reducing/elimin ting biases, and pre erving model interpretability). In addition, less complex ML 
algorith s and/or ML lgorithms with more human guidance may e used in addition to classical 
statistical approaches for the analysis of mor  rest icted databases, still possibly providing us ful, 
complementary infor atio . 
In the following sectio , we will further explore these c cepts by reviewing some examples of 
existing st di s th t implemented ML algorithms in the field of MDR-G B infections. In addition, 
different ML algorithms re chematically summarized in Table 1. 
Table 1. implified presentation of he po sible use of differ t achine earning alg rithms (also 
based on already existing and well-established statistical models)*. 
UNSUPERVISED SUPERVISED 
Clustering and dimensio ality reduction Regression task  
 SVD (s gular value decomposition)  Linear 
PCA (principal component analysis) Polyn mial 
 K-means D cisio  trees 
 Fuzzy -means  Ran om forest 
 Hierarchical clustering  
 Mixtu e of Gaussi ns  
 SOM (self-organizing maps) 
Association a alysis Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent pattern)-growth  K-nearest neighbor 
Hidden Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear discriminant nalysis  
* This is only a fracti n of avail ble machine learning algori ms and distincti n  i  categories re not 
abs lute. For example, some techniqu s present d  classifi a ion prob ems in the tabl  may ls  be 
u ed for r gr ssion problems, and some algorithms/t chniques may be u e  f  b th supervised an  
unsupervised objectiv s. 
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
In this section, we describe a case example f a r cent s udy exploiting he use of ML algorithms 
for depicting the risk of colonization [19] by exte ed-spectrum β-lactamases (ESBL)-produci g 
Enterobacterales (ESBL-PE), a type of MDR-GNB. Indeed, although colonization by MDR-GNB is not 
always followed by MDR-GNB infection (i.e., colonized patients may not devel p infection), the latter 
usually follows the former. Consequently, identifying modifiable risk factors on which to intervene 
for reducing the risk of colonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
A pri ri
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Consequently, cl ssical statistical mod ls and ML algorithms should be considered as a 
continuum in which, ge erally, t e fewer the ssumptions imposed by humans (e.g., human-made 
strict selection of v riables to b  included in he model) the more likely it is for ML algorithms to 
capture c mplex and composite characteristics (features) not easily recognized by humans, and to 
evaluate their associati n with the output label/s with high accuracy [17]. In this regard, two 
importa t concepts sho ld nec sarily be taken into account. First, capturing/designing complex 
features usu lly r quires a f r la ge  amou t of data than usually needed for classical risk prediction 
(th  fields of ML and “big data” are indeed deeply intertwined) [18]. Second, the general assu ption 
made just above (i.e., le s hu  guidance coupled with increased use of ML algorithms) should be 
vi wed ore as a ba kground tren  (over the continuum of classical statistical models and ML 
algorithms) rather th n an absolute ule. Indeed, human involvement also remain crucial in some 
co plex tasks erform  by ML alg rithms ( s an important guidance for pre-processing data, 
defining the lgorithm architectu e, ppropriately tuning the algorithm hyperparameters, 
reducing/ liminating biases, and preserving model interpretability). In addition, less complex ML 
lgorithms and/or ML algorithms with more human guidance may be used in addition to classical 
statistical approaches for the analysis of ore restricted databases, still possibly providing useful, 
complementary informatio . 
In the following s ctio , we will further explore these c cepts by reviewing some examples of 
existing t di  th t implemented ML algor hms in the field of MDR-GNB infections. In addition, 
diff rent ML lgorithms re chematically summarized in Table 1. 
Tabl  1. Simplifi d p esentation of he po sible use of differe t achine learning algorithms (also 
base  on already existing and well-established statistical models)*. 
UN UPERVISED SUPERVISED 
Clustering and dimensio ality reduction Regression task  
 SVD ( gular value decomposition)  Linear 
PCA (principal c mponent analysis) Polyn mial 
 K-m ans D cisio  trees 
 Fuzzy -means  Random forest 
 Hiera chical cluster g  
 Mixtu e of Gaussi s  
 SOM (self- rga izi g ps) 
A sociation a alysis Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent pattern)-growth  K-nearest neighbor 
Hidde  Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear discriminant analysis
* This i o ly a fracti n of av il ble machi e learning algori hms and distinctions i  categories re not 
bs lute. For exampl , s me techniqu s pr sen d fo  classifica ion prob ems in the tabl  may ls  be 
u e  or egr si  prob ems, and s me lgori hms/t chniques may be use  f  b th supervised and 
unsupervised objectiv s.
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
I  this section, we descri a case example f a recent study exploiting he use of ML algorithms 
for depicting the risk of colonization [19] by xtended-spectrum β-lactamases (ESBL)-producing 
E terobacterales (ESBL-PE), a t pe of MDR-GNB. Indeed, although colonization by MDR-GNB is not 
alw ys f llowed by MDR-GNB inf ction (i.e., colonized patients may not develop infection), the latter 
usually follows the former. Consequently, identifying modifiable risk factors on which to intervene 
for reducing the risk of c lonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
Deci tr es/random forest
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Consequently, classical statistic l models and ML algorithms s ould be considered as a
continuum in which, generally, the few r the ssumptions imp s d by humans (e.g., h m n-made
strict s lecti  of variables to b  included in the model) the more lik ly it is for ML algorith s
capture complex and composite c aracteristics (fe tures) not easily e ognized by umans, and t
evaluate their association with the ou pu  label/s with high accuracy [17]. In th s re ard, two
i po tant conc pts should necessarily b  aken into acco nt. First, capturing/designing c mplex
featur s usually requires a far larg r am unt of data han usually needed for classical r sk predic
(the fields of ML and “big d ta” are indeed de ply intertwined) [18]. S c nd, the ge eral s u ption
made just bove (i.e., less h man gui ance cou led with increased use of ML algorithms) should be
viewed or  as a background trend (over the continuu  of classic l st tistic l models  L
algorithms) rather than an absolute rule. Indeed, human involvem nt also remain crucial in some
co plex tasks performed by ML algorithms (as  impor ant guidance for pre-pr c ssing dat
defining the algorithm architecture, appropriately tuning the algorithm hyperparameters,
reducing/eliminating biases, and preserving mode  interpret bilit ). In ad ition, less comp ex ML
algorithms and/or ML algorithms w th more human gu dance may  used in ddition to cla sical
statistical approaches for the a alysis of more restricted databases, still possibly providing useful, 
complem ntary infor a . 
I  the following sectio , w  will further explore se c cepts by reviewing s me examples of
existing st di s th t i plement d ML algorith s n th  field of MDR-GNB infections. In addition, 
different ML algorithms re chematically summarized in Table 1. 
T ble 1. implified presentation of he po sible use of differ t achin  lear ing algorithms (also 
based on already existing and well-established statistical models)*. 
UNSUPERVISED SUPERVISED 
Clustering and dimensio ality reduction Regression task  
 SVD (s gular value decomposition)  Linear 
PCA (principal component analysis) Polyn mial 
 K-means D cisio  trees 
 Fuzzy -means  Ran om forest 
 Hierarchical clustering  
 Mixtu e of Gaussi ns  
 SOM (self-organizing maps) 
Association a alysi  Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent patter )-growth  K-nearest neighbo  
Hidden Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear dis r mina t nalysis
* This is only a fracti n of avail ble machin  l arning algori ms a d distincti  i  c tegories re not 
abs lute. Fo example, some techniqu s pres nt d  lassifi a ion prob ems in the tabl  may ls  be 
ed fo  r gr ssion problems, and some algorithms/t chniq es may b  u  f  b th sup rvised an  
unsupervised objectiv s. 
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
In this section, we describe a case example f a recent s udy exploiting he u e of ML alg rithms
for depicting the risk of colonization [19] by exte d -spectrum β-lactamases (ESBL)-produci g
Enterobacterales (ESBL-PE), a type of MDR-GNB. Indeed, although col nization by MDR-GNB is n t
alw ys fol o ed by MDR-GNB infection (i.e., colonized patients may not devel p i f ctio ), th  latter
usually follows the former. Consequently, identifying modifiable risk factors n which to intervene
for reducing the risk of colonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
F (frequ t pattern)-growth
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Consequently, classic l statistical models and ML algorithms s ould be considered as a
continuum in which, generally, t e few r the ssumptions imp s d by humans (e.g., human- ade
strict lec ion of variables to included i  the model) the more lik ly it is for ML algorithms
capt re c mplex and composite c aracteristics (features) not easily e ognized by umans, and t
evalu te their a so iat on with the outp  label/s with high accuracy [17]. In this regard, two
impo ta t concepts sho ld nec sar ly b  aken into acco nt. First, capturing/designing complex
featur s usually r quires a f r larg  amo t of data han usually needed for classical risk predic
(th  fields of ML and “big d ta” are indeed dee ly intertwined) [18]. S c nd, the general as umption
made j st above (i.e., less h n guidance coupl d with increased use of ML algorithms) should be
vi wed ore as a background tren  (over the continuum of classical statistic l models a d ML
algorithms) rather th n an absolute rule. Ind ed human involve ent also r main crucial in some
complex tasks perform  by ML algorith s ( s an important guidance for pre-processing data
defining he algorithm archit ctu e, ppropriately tuning the algorithm hyperparameters,
reducing/ liminating biases, n  preserving model interpretabilit ). In ad ition, less comp ex ML
lgorithms and/or ML algorithms w th more h man guidance may be used in addition to cla sical
statistical approaches for the a alysis of more restricted databases, still possibly providing useful, 
complem ntary informa . 
I  the following s ctio , w  will further explore se c cepts by reviewing s me examples of
existing t di th t i plement d ML algor h s n the field of MDR-GNB infections. In addition, 
diff rent ML lgorithms re schematically summarized in Table 1. 
T ble 1. Simplified p ese tation of the possible use of differ nt machine learning algorithms (also 
base  on already existing and well-established statistical models)*. 
UN UPERVISED SUPERVISED 
Clustering and dimensio ality reduction Regression task  
 SVD ( gular value decomposition)  Linear 
PCA (principal c mponent analysis) Polyn mial 
 K-m ans D cisio  trees 
 Fuzzy -means  Random forest 
 Hiera chical cluster g  
 Mixtu e of Gaussia s  
 SOM (self- rga izi g ps) 
A sociation a alysi  Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent patter )-growth  K-nearest neighbor 
Hidde  Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear dis r mina t nalysis
* This i ly a fracti n of av il ble machi e l arning algori hms a d distinctio s i  c tegories re not 
bs lute. Fo xampl , s me techniqu s pr s n d for lassifica ion prob ems in the tabl  may als  be 
e  o  egre si  prob ems, and s me lgori hms/t chniques may b  use  f  b th sup rvised and 
unsupervised objectiv s.
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
I  this section, we describ a case example of a recent study exploiting he u e of ML alg rithms
for depic ing t e risk of colonization [19] by extend -spectrum β-lactamases (ESBL)-producing
Enterobacterales (ESBL-PE), a t p  of MDR-GNB. Indeed, although col nization by MDR-GNB is not
alw ys fol o d by MDR-GNB infection (i.e., colonized patients may not devel p infection), th  latter
usu lly follows the former. Consequently, identifying modifiable risk factors n which to intervene
for reducing the risk of c lonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
K- r s neighb r
Hidde Mark v model
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Consequently, cl ssic l statistical models and ML algorithms s ould be conside ed as a 
on inuum in which, ge erally, the few r the assumptions imp s d by humans (e.g., human- ade 
strict lec ion of v riables to e included i  he model) t e more lik l  it is for ML algorithms  
capt re complex and c mposite c aracteristics (fea ures) not asily e ognized by umans, and t  
eval ate their a so iati n with the outpu  label/s with high accuracy [17]. In this regar , wo 
impo ta t concepts shoul  necessarily b  aken into acco nt. First, capturing/designing complex 
fe tur s usu lly requir s a f r la g r amo nt of data han usually needed for cl ssical risk predic  
(the fields f ML and “bi  d ta” a  indeed dee ly i tertwined) [18]. S c nd, the general as umption 
made j st above (i.e., le s h  guidance coupled with increased use of ML algorithms) should b  
viewed ore as a ba kgr und trend ( ver the continuum of classi al statistic l m d l  a d ML 
algorithms) rather than an absolute ule. Indeed, human i volvement also re ain cruci l in some 
complex tasks performe  by ML alg ith s (as an important guida ce for pre-pro essing data  
defining he lgorithm arc it cture, appropri tely tuning the algorithm hyperparameters, 
reducing/elimin ting biases, an  pre erving model interpretabilit ). In ad ition, less comp ex ML 
algorith s and/or ML lgorithms w th more h man guidance may be used in addition to cla sical
statistical approaches for the a alysis of or  rest ic ed databases, still possibly providing us ful, 
complem ntary infor a . 
I  the following sectio , we will further explore se c cepts by reviewing s me examples of
existing tudie that i plement d ML algorith s n the field of MDR-GNB infections. In addition, 
diff rent ML lgorithms are schematically summarized in Table 1. 
T ble 1. Simplified prese tation of the possible use of differ nt machine learning algorithms (also 
based on already existing and well-established statistical models)*. 
UNSUPERVISED SUPERVISED 
Clustering and dimensionality reduction Regression task  
 SVD ( ngular value decomposition)  Linear 
PCA (principal c mponent analysis) Polynomial 
 K-m ans D cisio  trees 
 Fuzzy k-means  Random forest 
 Hiera chical cluster g  
 Mixtu e of Gaussia s  
 SOM (self- rga izi g ps) 
A sociation a alysi  Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent patter )-growth  K-nearest neighbor 
Hidden Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear dis r mina t nalysis
* This is ly a fracti n of av ilable machine learning algorithms a d distinctio s i  c tegories re not 
absolute. Fo exampl , s me techniqu s pr s nt d for lassifica ion prob ems in the tabl  may also be 
e  o  egre si  prob ems, and s me algori hms/t chniques may b  use  f  b th sup rvised and 
unsupervised objectiv s.
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
In this section, we descri e a case example f a r cent s udy exploiting he u e of ML alg rithms 
for depic ing t e risk of colonization [19] by xten -spectrum β-lactamases (ESBL)-producing 
E terobacterales (ESBL-PE), a type of MDR-GNB. Indeed, although col nization by MDR-GNB is not 
alw ys f l o d by MDR-GNB inf ction (i.e., colonized patients may not devel p infection), th  latter 
usu lly follows the former. Consequently, identifying modifiable risk factors n which to intervene
for reducing the risk of colonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
Neur l networks
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Consequently, cl ssical statistic l models and ML algorithms s ould be conside ed as a
on inuum in which, ge erally, t e few r the ssumptions imp s d by humans (e.g., hum n- ade
strict s l cti  of v riables to b  included in he model) t e more lik l  it is for ML algorith s
capture complex and c mposite c aracteristics (fe ures) not easily e ognized by umans, and t
eval ate their associati n with the outpu  label/s with high accuracy [17]. In this regar , two
i po ta t conc pts shoul  necessarily b  aken into acco nt. First, capturing/designing c mplex
fe tur s usu lly requir  a f r la g r am u t of data han usually needed for cl ssical risk predic
(the fields f ML and “bi  d ta” a  indeed de ly i tertwined) [18]. S c nd, the ge eral as umption
made just bove (i.e., le s h  gui ance coupled with ncreased use of ML algorithms) should b
vi wed or  as a ba kground trend (over the continuum of classic l statistic l m d l  d ML
lgorithms) rather than an absolute ule. Indeed, human i volvement also re ain cruci l in some
complex tasks perform  by ML alg ithms ( s  important guida ce for pre-pr essing dat
defining the lgorithm arc itecture, appropri tely tuning the algorithm hyperparameters,
reducing/ limin ting biases, and pre erving model interpretabilit ). In ad ition, less comp ex ML 
algorith s and/or ML lgorithms w th more human guidance may e used in addition to cla sical
statistical approaches for the a alysis of or  rest icted databases, still possibly providing us ful, 
complem ntary infor a . 
I  the following section , we will further explore se concepts by reviewing s me examples of
existing tudie  that i plement d ML algorith s n the field of MDR-GNB infections. In addition, 
diff rent ML lgorithms are schematically summarized in Table 1. 
T ble 1. Simplified presentation of the possible use of differ nt machine learning algorithms (also 
based on already exis ing and well-established statistical models)*. 
UNSUPERVISED SUPERVISED 
Clustering and dimensionality reduction Regression tasks 
 SVD ( ingular value decomposition)  Linear 
 PCA (principal c mponent analysis)  Polynomial 
 K-m ans  Decision trees 
 Fuzzy k-means  Random forest 
 Hiera chical cluster g  
 Mixtu e of Gaussia s  
 SOM (self- rga izi g ps) 
A sociation a alysi  Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent patter )-growth  K-nearest neighbor 
Hidden Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear dis r mina t nalysis
* This is only a fraction of available machine learning algorithms a d distinctio s i  c tegories re not 
absolute. Fo  exampl , s me techniques pr s nt d for lassifica ion problems in the tabl  may also be 
se  o  egre si  prob ems, and s me algori hms/techniques may b  used f  b th sup rvised and 
unsupervised objectives.
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
In this section, we descri e a case example f a r cent s udy exploiting he u e of ML alg rithms
for depicting the risk of colonization [19] by xte -spectrum β-lactamases (ESBL)-produci g
E terobacterales (ESBL-PE), a type of MDR-GNB. Indeed, although col nization by MDR-GNB is not
alw ys f l o ed by MDR-GNB inf ction (i.e., colonized patients may not devel p infection), th  latter 
usually follows the former. Consequently, identifying modifiable risk factors n which to intervene
for reducing the risk of colonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
SVM (support vector machines)
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Consequently, cl ssical statistic l models and ML algorithms s ould be conside e  as a 
on inuum in which, generally, t e few r the ssumptions i p s d by humans (e.g., hum n-made 
strict s lecti  of variables to b  included in the model) t e more lik l  it is for ML algorith s  
capture complex and c mposite c aracteristics (fe ures) not easily e ognized by umans, and t  
eval ate their association with the outpu  label/s with high accuracy [17]. In this regar , two 
i po ta t conc pts shoul  necessarily b  aken into acco nt. First, capturing/designing c mplex 
fe tur s usually requir s a far larg r am unt of data han usually needed for cl ssical risk predic  
(the fields f ML and “bi  d ta” a  indeed de ly i tertwin d) [18]. S c d, the ge eral as umption 
made just bove (i.e., less h an gui anc  cou led with increased use of ML algorithms) should b  
vi wed or  as a background trend (over the continuum of classic l statistic l m d l  d L 
algorith s) rather than an absolute ule. Indeed, human i volvement also re ain cruci l in some 
complex tasks perform  by ML algo ithms ( s  important guida ce for pre-pr essing dat  
defining the algorithm arc itecture, appropri tely tuning the algorithm hyperparameters,
reducing/elimin ting biases, and pre erving model interpretabilit ). In ad ition, less comp ex ML 
algorith s and/or ML lgorithms w th more human guidance may e used in addition to cla sical
statistical approaches for the a alysis of mor  rest icted databases, still possibly providing us ful, 
complem ntary infor a . 
I  the following section , we will further explore se concepts by reviewing s me examples of
existing tudie  that i plement d ML algorith s n the field of MDR-GNB infections. In addition, 
different L alg rithms are schematically summarized in Table 1. 
T ble 1. mplified presentation f the possible use of differ nt machine le rning alg ithms (also 
based on already exis ing and well-established statistical models)*. 
UNSUPERVISED SUPERVISED 
Clustering and dimensionality reduction Regression tasks 
 SVD ( ingular value decomposition)  Linear 
 PCA (principal c mponent analysis)  Polynomial 
 K-m ans  Decision trees 
 Fuzzy k-means  Random forest 
 Hiera chical cluster g  
 Mixture of Gaussia s  
 SOM (self- rga izi g ps)  
A sociation analysi  Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent patter )-growth  K-nearest neighbor 
Hidden Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear dis r mina t nalysis)
* This is only a fraction of available machine learning algorithms a d distinctio s in c tegories re not 
absolute. Fo exampl , s me techniques pr s nt d for lassification problems in the table may also be 
se  o  regre si  prob ems, and s me algori hms/techniques may b  used for b th sup rvised and 
unsupervised objectives.
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
In this section, we describe a case example f a r cent s udy exploiting he u e of ML alg rithms 
for depicting the risk of colonization [19] by exte -spectrum β-lactamases (ESBL)-produci g 
Enterobacterales (ESBL-PE), a type of MDR-GNB. Indeed, although col nization by MDR-GNB is not
alw ys fol o ed by MDR-GNB infection (i.e., colonized patients may not devel p infection), th  latter 
usually follows the former. Consequently, identifying modifiable risk factors n which to intervene
for reducing the risk of colonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
Naive Bayes
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Consequently, cl ssical statistic l models and ML algorithms s ould be conside e  as a
n inuum in which, generally, the few r the ssumptions imp s d by humans (e.g., hum n-made
strict s lecti  of variables to b  included in the model) t e more lik l  it is for ML algorith s
capture complex and c mposite c aracteristics (fe ures) not easily e ognized by umans, and t
eval ate their association with the outpu  label/s with high accuracy [17]. In this regar , two
i po tant conc pts shoul  necessarily b  aken into acco nt. First, capturing/designing c mplex
fe tur s usually requir s a far larg r amount of data han usually needed for cl ssical risk predic
(the fi lds f ML a d “bi  d ta” a  indeed e ply i tertwined) [18]. S c nd, the ge eral as u ption
made just bove (i.e., less h an gui ance cou led with increased use of ML algorithms) should b
viewed or  as a background trend (over the continuum of classic l statistic l mod l  d L
algorith s) rather than an absolute ule. Indeed, human i volvement also re ain cruci l in some
co plex tasks perfor ed by ML algo ithms (as  important guida ce for pre-pr essing dat  
defining the algorithm arc itecture, appropri tely tuning the algorithm hyperparameters,
reducing/elimin ting biases, and pre erving model interpretabilit ). In ad ition, less comp ex ML 
algorith s and/or ML lgorithms w th more human guidance may e used in addition to cla sical
statistical approaches for the analysis of mor  rest icted databases, still possibly providing us ful, 
complem ntary infor a . 
I  the following section , we will further explore se concepts by reviewing s me examples of
existing studies that i plement d ML algorith s n the field f MDR-GNB infections. In addition, 
diff rent ML lg rithms are chematically summarized in Table 1. 
T ble 1. implified prese tation f he po sible use of differ t achine learning algorithms (also 
based on already exis ing and well-established statistical models)*. 
UNSUPERVISED SUPERVISED 
Clustering and dimensionality reduction Regression tasks 
 SVD ( ingular value decomposition)  Linear 
 PCA (principal component analysis)  Polynomial 
 K-means  Decision trees 
 Fuzzy k-means  Random forest 
 Hierarchical clustering  
 Mixture of Gaussia s  
 SOM (self- rga zing ps)  
A sociation analysis Classification tasks 
 A priori  Decision trees/random forest 
 FP (frequent pattern)-growth  K-nearest neighbor 
Hidden Markov model  Neural networks 
  SVM (support vector machines) 
  Naive Bayes 
  LDA (linear dis r minant nalysis)
* This is only a fraction of available machine learning algorithms a d distinctio s in c tegories re not 
absolute. Fo exampl , s me techniqu s pr sent d fo  lassification problems in the table may lso be 
se  o  egr si n prob ems, and s me algori hms/techniques may be used for both supervised and 
unsupervised objectives.
4. ML Algorithms for Predicting the Risk of Developing MDR-GNB Infections 
In this section, we describe a case example f a r cent s udy exploiting he u e of ML alg rithms
for depicting the risk of colonization [19] by exte -spectrum β-lactamases (ESBL)-produci g 
Enterobacterales (ESBL-PE), a type of MDR-GNB. Indeed, although col nization by MDR-GNB is not
alw ys fol o ed by MDR-GNB infection (i.e., colonized patients may not devel p infection), th  latter 
usually follows the former. Consequently, identifying modifiable risk factors n which to intervene
for reducing the risk of colonization is intuitively a good, indirect way to prevent MDR-GNB 
infection. 
L A (linear discriminant analysis)
* This is on y a r ction of va la l a in l ar ing algorit ms and distinctions categori ot absolute.
F example, o techniques p es nt d for classification problems in the table may also b use for regression
problems, and some algorithms/techniques may be used for both supervised and unsupervised objectives.
4. ML Algorit m for P edi ti g t e Ri k of D veloping DR-GNB Infections
In t is s ction, we d scribe a case xample of a recent study xploiting he use of ML algorithms
f r d icti g the r k of c lo iz ion [19] by exte pectrum β-l ctamases (ES L)-producing
Enterobacterales (ESBL-PE), a type of DR-GNB. Indeed, although col nization by MDR-GNB is not
always followed by MDR-GNB infection (i.e., colonized patients may not develop infection), the latter
usually follows the former. Consequently, identifying modifiable risk factors on which to intervene for
reducing the risk colonizat n is tu tiv ly a g od, indir ct way to prevent MDR-GNB infection.
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The study performed by Tacconelli and colleagues is a good example of combining classical
statistical techniques and ML algorithms to provide useful complementary information [19]. First,
the authors used flexible parametric survival models (adjusted for colonization pressure and ward
of hospital stay) and identified previous antibiotic exposure as one of the independent predictors of
ESBL-PE colonization (hazard ratio 2.38, 95% confidence intervals [CI] 1.29–4.40, p = 0.006). Then, they
employed a random forest algorithm (a ML technique consisting of aggregating the results of separated
decision trees, see Table 1) in order to translate a complex interaction of different features (number of
used antibiotics, use of combinations of antibiotics, sequential use of antibiotics, length of antibiotic
therapy, baseline patients’ characteristics) in a simple rank of different antibiotic classes in terms of
their influence on the risk of developing ESBL-PE colonization. Eventually, this approach provided
useful additional information, by ranking previous monotherapy to be more at risk of promoting
ESBL-PE colonization than previous combination therapy, and cephalosporins to be the most influential
single antibiotic class. Of note, the authors initially trained different ML algorithms (linear support
vector machine (SVM) with radial basis function kernel, neural network, random forest, and others)
and ultimately selected the random forest algorithm on the basis of the best performance on the
cross-validation set in terms of accuracy, overfitting, and permutation significance [19]. This further
testified to the role of thoughtful human guidance of optimizing the application of ML techniques to
specific risk prediction tasks.
5. ML Algorithms for Predicting the Risk of MDR-GNB Etiology in Patients with Sign and
Symptoms of Infection
At the bedside of a patient with sign and symptoms of infection, it is critical to recognize the risk
of MDR-GNB etiology, since it allows prompt initiation of an empirical treatment also covering MDR
organisms. This to avoid the increase in mortality associated with a delayed administration of an active
therapy [20–22]. On the other hand, MDR-GNB-covering agents should not be used indiscriminately
in patients not a risk, since their misuse may lead to the perpetuation of resistance selection [23,24].
In their multicenter, retrospective study among 1288 patients with Enterobacterales bacteremia,
Goodman and colleagues employed a classical, multivariable logistic regression approach for creating
a risk score based on regression coefficients for predicting the likelihood of ESBL-PE etiology at the
bedside of bacteremic patients, and compared its performance with that of risk assessment using
a classification and regression tree approach (CART analysis) [25]. Overall, the two approaches
performed similarly in the study of Goodman and colleagues, with 49.5% sensitivity and 99.5%
specificity for the classical risk score and 51.0% sensitivity and 99.1% specificity for the decision tree.
Regarding the use of both classical and ML models, in our opinion the most interesting point in this
paper was not their possible complementarity, but, the difference in their respective advantages against
a backdrop of similar overall performance, which may alternatively prioritize the use of one approach
over the other in different situations. For example, from a research perspective, while the classical
logistic regression approach requires more assumptions a priori and may struggle with collinearity,
these are not limitations of CART analysis, which also usually allows higher predictor-to-event ratios
than classical logistic regression models [25,26]. On the other hand, CART analyses could be more
prone to overfitting than classical models (and consequently perform more poorly on new data) [27].
From a clinical perspective, the major advantage of the classical logistic regression-based approach
is its adaptability (i.e., sensitivity or specificity may be preferably prioritized in any given situation
by shifting the cut-off), while the major advantage of CART analysis is perhaps its user-friendliness
(e.g., in Goodman’s study it was based on only five variables and did not require end user calculation,
while the classical score required 14 variables to be considered, as well as the compilation of the final
summary score by the user).
Overall, we think the study by Goodman and colleagues suggest that a careful balance of the
peculiarities and disadvantages of the two approaches still remains critical both (i) to identify the most
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suitable model for a given research or clinical task, and (ii) to precisely evaluate if and how to exploit a
combined approach to obtain precious complementary information.
6. ML Algorithms to Guide Antibiotic Stewardship and Prevent Further Emergence
of MDR-GNB
Antibiotic stewardship may be defined as a coherent set of actions designed to use antimicrobials
responsibly (for example, but not only, optimal selection, dose, and duration of therapy) in humans,
animals, and the environment, within a One Health approach [28–30]. In hospitals, these actions are
intended not only for improving treatment of the patient receiving (or not receiving) antibiotic/s, but also
for preventing/delaying the emergence of resistance that may disseminate to other patients. From
the perspective of this enlarged and complex target population, the impact of antibiotic stewardship
interventions may be complex to evaluate.
Beaudoin and colleagues employed a two-step ML approach (temporal abstraction followed by
temporal induction classification models) to build a clinical decision support system able to learn
classification rules for labeling inappropriate antibiotic prescriptions (based on a training set of past
stewardship recommendations on antibiotic dose adjustment, discontinuation, and de-escalation in a
Canadian hospital) [31]. The performance of the learning module was then evaluated prospectively,
alongside with that of the classical antibiotic stewardship intervention already implemented in the
hospital. Interestingly, by expanding the rules for identifying inappropriate prescriptions, the learning
module was able to label inappropriate prescribing practices (i.e., not supported by local experts) that
were missed by the standard antibiotic stewardship intervention rules [31].
Although several limitations were identified by the authors (e.g., how to address alterations,
substitutions, and maintenance of old and new rules over time, and how to adequately manage
non-binary antibiotic stewardship classification problems), this example testifies to the potential
usefulness of ML for supporting antibiotic stewardship teams that need to simultaneously and
continuously evaluate and control prescriptions in several large wards in large hospitals, with the final
aims of both optimizing patients’ cure and prevent the emergence and dissemination of difficult-to-treat
resistant organisms such as MDR-GNB.
7. Conclusions
In this review, we selected and discussed three examples of the interaction between
researchers/clinicians dealing with MDR-GNB and ML algorithms. Of course, there are other valuable
examples of application of ML to antimicrobial resistance, but it should be noted that our aim was mainly
that of introducing the potential usefulness of wisely coupling current research approaches with ML
techniques to improve our ability to deal with routine MDR-GNB risk prediction at patients’ bedside.
It is also important to note that we limited our review to ML algorithms trained on clinical (patients’
characteristics and recorded clinical features) and laboratory data (phenotypical identification and
susceptibility test) usually available in routine clinical practice in most hospitals. In this regard, the
possible dissemination and appropriate use of innovative tests able to provide information on either
the precise mechanisms of resistance or other phenotypic/genotypic features of MDR-GNB may further
and considerably improve the ability of ML algorithms to help clinicians predicting MDR-GNB risks in
routine care [32,33]. Very importantly, this should occur against a background of wide adherence to
the FAIR principles (findable, accessible, interoperable, and reusable) connected to the availability of
standardized systems [34–38].
In conclusion, in the next few years we expect to witness an increasingly large number of
research studies perfecting the application of ML techniques in the field of MDR-GNB infections.
Very importantly, this cannot be separated from the availability of a continuously refined and updated
ethical framework allowing an appropriate use and sharing of the large datasets of medical data
needed to build efficient ML-based support systems.
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